Therapeutic Goods Act 1989
I, Mayada Kayali, (A/g) Assistant Secretary, Complementary and Over the Counter Medicines Branch, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health for the purposes of section 42 DK (1) of the Therapeutic Goods Act, give notice that the restricted representations described in paragraph (a) below, being representations that are necessary for the appropriate use of the therapeutic goods described in paragraph (b) below, may be included either on the label of the package of the goods or in information included in the package in which those goods are contained:
- Representations to the effect that the goods described in paragraph (b) below may be used to "Reduces the risk of heart attack and stroke in patients with known cardiovascular or cerebrovascular disease by helping to prevent blood clotting."
- TERRYWHITE CHEMMART LOW DOSE ASPIRIN aspirin 100mg enteric coated tablet blister pack (AUST R 300092)
Dated this 20 Day of March 2018,
Mayada Kayali
Delegate of the Secretary to the Department of Health; and
(A/g) Assistant Secretary, Complementary and Over the Counter Medicines Branch